Mauritius vs Mus: HIV-positive TB patients on ART (antiretroviral therapy)
Mauritius
100.0%
in 2024
Mus
100.0%
in 2024
Mauritius rank
1st
Mus rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Mauritius
- Mus
How they compare
Mauritius currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
Across all 22 years both countries report, Mus has been ahead every year.
Mauritius ranks 1st and Mus ranks 1st of 144 countries.
Head to head by decade
| Decade | Mauritius | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.0% | 72.0% | 0.0% | — |
| 2010s | 86.2% | 86.2% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Mauritius or Mus?
- Mauritius, at 100.0% against 100.0% in Mus as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Mauritius and Mus?
- 0.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Mus?
- 22 years are reported by both, from 2003 to 2024.
- How do Mauritius and Mus rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Mauritius ranks 1st and Mus ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.